Liposomal drug delivery systems: an update review.
By A. Samad, Y. Sultana, M. Aqil. Current Drug Delivery, 2007
906 citations recorded by the source corpus.
Subfields: Biomaterials, Oncology, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/bf0455ac76d99cb1084283a406daa60b9695e4d2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
Citations in the corpus
- Targeted Delivery of Pesticides Using Biodegradable Polymeric Nanoparticles (2013, background): “They have attracted the attention of a number of research groups in various fields, such as physical chemistry, biophysics, and pharmaceutics because of their structure (which is comparable to the phospholipid membranes of living cells) (Samad et al. 2007).”
- Nanoparticles for Cancer Therapy: Current Progress and Challenges (2021, background): “Liposomes are unique in having characteristics such as low intrinsic toxicity, weak immunogenicity, and biological inertness [73].”
- Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. (2013, background): “The advantage of liposomes is that they can carry hydrophilic, lipophilic as well as amphoteric drug molecules either entrapped inside the liposomes or bound to the micellar surface (Samad et al., 2007; Vyas and Sihorkar, 2001).”